Adderall and Amoxicillin Shortages Raise Questions about Transparency and Accountability in Big Pharma
But when makers of generics compete mainly on price and aren’t forced to consider reliability, the marketplace can break down when demand surges or supply chains are disrupted, according to Ozlem Ergun, a distinguished professor of mechanical and industrial engineering at Northeastern University, who served with Fox on the committee. (featured in NBC News)